Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.